Durect Corp (FRA:DC8A)
€ 0.81 -0.015 (-1.88%) Market Cap: 25.87 Mil Enterprise Value: 29.05 Mil PE Ratio: 0 PB Ratio: 22.56 GF Score: 60/100

DURECT Corporation - Special Call Transcript

Nov 20, 2020 / 06:00PM GMT
Release Date Price: €14.3 (-2.72%)
James E. Brown
DURECT Corporation - Co-Founder, CEO, President & Director

Good morning everyone, and good afternoon to those who are on the East Coast. It's wonderful to be able to speak with you today, and I want to thank you all for joining us, and it is my pleasure to introduce to you Dr. Norman Sussman, our Chief Medical Officer.

Norman L. Sussman
DURECT Corporation - Chief Medical Officer

Thank you, Jim. Good -- I guess, depending where you are, good morning or good afternoon, everyone. As Jim said, I'm Norman Sussman. I've recently joined DURECT Corporation. I'll explain a little bit about that story as we go on.

Just to orient you, I have been a hepatologist, that is a liver doctor for almost the last 20 years. It's the only thing I've done, is see patients with liver disease. And you'll see why I'm so excited about today's presentation.

This is the -- these are forward-looking statements. And instead of reading this, I encourage you to look at our SEC filings. And here's what I'm going to talk about today. We're going to talk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot